According to some authors P-tau181, which quantifies phosphorylated tau protein at amino acid threonine 181 in human blood plasma, constitutes the most reliable biomarker of future evolution of AD (Janelidze et al., 2020; Karikari et al., 2020). Here, MAPT is linked to Alzheimer disease.